Wealth Enhancement Advisory Services
URGN icon

Wealth Enhancement Advisory Services’s UroGen Pharma URGN Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$295K Buy
+7,642
New +$207K ﹤0.01% 3225

Other funds holding URGN

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
BCM
Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wealth Enhancement Advisory Services's URGN Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in UroGen Pharma (URGN) in Q2 2026: 7,642 shares worth $295K. The stake represents ﹤0.01% of the portfolio and ranks #3225 among its holdings.

15 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • Wealth Enhancement Advisory Services held 7,642 shares of UroGen Pharma worth $295K as of Q2 2026.
  • UroGen Pharma was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • UroGen Pharma made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3225 holding.
  • 15 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.